

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 8.64304051 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.58594657 |
| 3 | exogenous drug catabolic process (GO:0042738) | 8.32151318 |
| 4 | glyoxylate metabolic process (GO:0046487) | 8.19838613 |
| 5 | drug catabolic process (GO:0042737) | 8.17081631 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 7.83349102 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.83349102 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 7.36304594 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25685280 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 7.25685280 |
| 11 | regulation of protein activation cascade (GO:2000257) | 7.15659226 |
| 12 | fibrinolysis (GO:0042730) | 6.78820679 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.72479649 |
| 14 | protein carboxylation (GO:0018214) | 6.72479649 |
| 15 | omega-hydroxylase P450 pathway (GO:0097267) | 6.72417297 |
| 16 | complement activation, alternative pathway (GO:0006957) | 6.68281595 |
| 17 | regulation of complement activation (GO:0030449) | 6.64717801 |
| 18 | urea metabolic process (GO:0019627) | 6.49335491 |
| 19 | cellular glucuronidation (GO:0052695) | 6.24237617 |
| 20 | blood coagulation, intrinsic pathway (GO:0007597) | 6.13911835 |
| 21 | negative regulation of sterol transport (GO:0032372) | 6.04105036 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 6.04105036 |
| 23 | uronic acid metabolic process (GO:0006063) | 5.94347321 |
| 24 | glucuronate metabolic process (GO:0019585) | 5.94347321 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.88037794 |
| 26 | ethanol oxidation (GO:0006069) | 5.83885199 |
| 27 | drug metabolic process (GO:0017144) | 5.64385830 |
| 28 | bile acid biosynthetic process (GO:0006699) | 5.64329287 |
| 29 | urea cycle (GO:0000050) | 5.60694191 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.60498823 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 5.59056967 |
| 32 | phenylpropanoid metabolic process (GO:0009698) | 5.52875582 |
| 33 | oxidative demethylation (GO:0070989) | 5.52480269 |
| 34 | regulation of plasminogen activation (GO:0010755) | 5.44438730 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 5.38172072 |
| 36 | bile acid metabolic process (GO:0008206) | 5.28792933 |
| 37 | glycine metabolic process (GO:0006544) | 5.13652134 |
| 38 | negative regulation of hemostasis (GO:1900047) | 5.02173727 |
| 39 | negative regulation of blood coagulation (GO:0030195) | 5.02173727 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.96485818 |
| 41 | phospholipid efflux (GO:0033700) | 4.87663797 |
| 42 | intestinal cholesterol absorption (GO:0030299) | 4.80245780 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.79477425 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.79477425 |
| 45 | ethanol metabolic process (GO:0006067) | 4.73734444 |
| 46 | bile acid and bile salt transport (GO:0015721) | 4.72857757 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.62470700 |
| 48 | negative regulation of coagulation (GO:0050819) | 4.59746568 |
| 49 | protein activation cascade (GO:0072376) | 4.56487620 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.55991897 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.55991897 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55991897 |
| 53 | negative regulation of wound healing (GO:0061045) | 4.50964941 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.50442952 |
| 55 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.50299297 |
| 56 | cholesterol efflux (GO:0033344) | 4.45922640 |
| 57 | high-density lipoprotein particle remodeling (GO:0034375) | 4.42972428 |
| 58 | positive regulation of blood coagulation (GO:0030194) | 4.38433174 |
| 59 | positive regulation of hemostasis (GO:1900048) | 4.38433174 |
| 60 | acute-phase response (GO:0006953) | 4.33485970 |
| 61 | S-adenosylmethionine metabolic process (GO:0046500) | 4.32946199 |
| 62 | negative regulation of protein activation cascade (GO:2000258) | 4.29867480 |
| 63 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.29171309 |
| 64 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.29171309 |
| 65 | tyrosine metabolic process (GO:0006570) | 4.28251438 |
| 66 | alkaloid metabolic process (GO:0009820) | 4.27911291 |
| 67 | negative regulation of lipase activity (GO:0060192) | 4.22331058 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.16555689 |
| 69 | regulation of humoral immune response (GO:0002920) | 4.14461089 |
| 70 | hormone catabolic process (GO:0042447) | 4.08748606 |
| 71 | complement activation, classical pathway (GO:0006958) | 4.07122834 |
| 72 | complement activation (GO:0006956) | 4.05723281 |
| 73 | positive regulation of coagulation (GO:0050820) | 4.04673299 |
| 74 | arginine metabolic process (GO:0006525) | 4.00708135 |
| 75 | reverse cholesterol transport (GO:0043691) | 3.98594987 |
| 76 | polyketide metabolic process (GO:0030638) | 3.91358608 |
| 77 | doxorubicin metabolic process (GO:0044598) | 3.91358608 |
| 78 | daunorubicin metabolic process (GO:0044597) | 3.91358608 |
| 79 | heme transport (GO:0015886) | 3.87202573 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.83155991 |
| 81 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.79776277 |
| 82 | alpha-amino acid catabolic process (GO:1901606) | 3.77321127 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.76820510 |
| 84 | regulation of lipoprotein particle clearance (GO:0010984) | 3.74509764 |
| 85 | negative regulation of complement activation (GO:0045916) | 3.73268917 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.69824504 |
| 87 | response to mercury ion (GO:0046689) | 3.69034860 |
| 88 | steroid catabolic process (GO:0006706) | 3.66708310 |
| 89 | aromatic amino acid family metabolic process (GO:0009072) | 3.63714656 |
| 90 | glutamate metabolic process (GO:0006536) | 3.63400738 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.62289563 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61751763 |
| 93 | indole-containing compound catabolic process (GO:0042436) | 3.59686179 |
| 94 | indolalkylamine catabolic process (GO:0046218) | 3.59686179 |
| 95 | tryptophan catabolic process (GO:0006569) | 3.59686179 |
| 96 | serine family amino acid biosynthetic process (GO:0009070) | 3.56930771 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 3.49999338 |
| 98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.49717579 |
| 99 | primary alcohol catabolic process (GO:0034310) | 3.47546179 |
| 100 | xenobiotic metabolic process (GO:0006805) | 3.47095115 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.19665649 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.81346884 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.02019535 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.68085983 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.86723287 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.72986521 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.43879073 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08684131 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04119014 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.49691747 |
| 11 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.48722516 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.44839100 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.18088914 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3669500 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50357576 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.48852475 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46882985 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35934355 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32235308 |
| 20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.24967312 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17796091 |
| 22 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17414582 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17053982 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13252154 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11456513 |
| 26 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10318477 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08485477 |
| 28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05425164 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04685009 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03580959 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02106967 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98959213 |
| 33 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98507892 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94369158 |
| 35 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92269561 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91991150 |
| 37 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90064144 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88977149 |
| 39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86071718 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85751765 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84441216 |
| 42 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83298884 |
| 43 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80013321 |
| 44 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78662695 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78001557 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77402087 |
| 47 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.76859550 |
| 48 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75977178 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73236108 |
| 50 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.72312958 |
| 51 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72047671 |
| 52 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70841640 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70481157 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.70359468 |
| 55 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.69898416 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.69768497 |
| 57 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68807395 |
| 58 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67878082 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66203341 |
| 60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.65918150 |
| 61 | CBP_21632823_ChIP-Seq_H3396_Human | 0.64805788 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.64690282 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63489753 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.62102620 |
| 65 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.62062785 |
| 66 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.61926264 |
| 67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.61612807 |
| 68 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.60629753 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.59197553 |
| 70 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.58845350 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58727797 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58684804 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.58270504 |
| 74 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.57743230 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56222168 |
| 76 | NFYA_21822215_ChIP-Seq_K562_Human | 0.55583769 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.55387244 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.55100802 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54667010 |
| 80 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.54446589 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.54268452 |
| 82 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53860682 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.53004433 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52902854 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 0.51973177 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.51686077 |
| 87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.51663911 |
| 88 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51402045 |
| 89 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.51302199 |
| 90 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51298360 |
| 91 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.51290497 |
| 92 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.50155755 |
| 93 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.50040979 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.49910222 |
| 95 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.48923772 |
| 96 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.48882405 |
| 97 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.48817924 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48797759 |
| 99 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.48749028 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.48667182 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.61215702 |
| 2 | MP0005360_urolithiasis | 6.28092414 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.13756831 |
| 4 | MP0005365_abnormal_bile_salt | 6.05557200 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.22493772 |
| 6 | MP0003195_calcinosis | 5.16978120 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.57289643 |
| 8 | MP0003868_abnormal_feces_composition | 4.01306115 |
| 9 | MP0003252_abnormal_bile_duct | 3.89809813 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.81197000 |
| 11 | MP0009697_abnormal_copulation | 3.03675906 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.93978428 |
| 13 | MP0009840_abnormal_foam_cell | 2.60939637 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.38409170 |
| 15 | MP0005332_abnormal_amino_acid | 2.30369188 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.21052890 |
| 17 | MP0000609_abnormal_liver_physiology | 1.82674575 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.73737726 |
| 19 | MP0001764_abnormal_homeostasis | 1.67624489 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.61156496 |
| 21 | MP0005408_hypopigmentation | 1.45487325 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.34089383 |
| 23 | MP0010368_abnormal_lymphatic_system | 1.27026121 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.19840741 |
| 25 | MP0002132_abnormal_respiratory_system | 1.07509779 |
| 26 | MP0000598_abnormal_liver_morphology | 1.04997813 |
| 27 | MP0001915_intracranial_hemorrhage | 1.01918426 |
| 28 | MP0005451_abnormal_body_composition | 1.00197347 |
| 29 | MP0001661_extended_life_span | 0.99211345 |
| 30 | MP0009643_abnormal_urine_homeostasis | 0.98135748 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97724977 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 0.91770605 |
| 33 | MP0000604_amyloidosis | 0.91160703 |
| 34 | MP0009053_abnormal_anal_canal | 0.89545060 |
| 35 | MP0003186_abnormal_redox_activity | 0.87171662 |
| 36 | MP0009642_abnormal_blood_homeostasis | 0.85572187 |
| 37 | MP0005376_homeostasis/metabolism_phenot | 0.79136940 |
| 38 | MP0003879_abnormal_hair_cell | 0.78604552 |
| 39 | MP0005058_abnormal_lysosome_morphology | 0.77219606 |
| 40 | MP0008469_abnormal_protein_level | 0.76829785 |
| 41 | MP0005187_abnormal_penis_morphology | 0.76373268 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.75173120 |
| 43 | MP0005395_other_phenotype | 0.73031468 |
| 44 | MP0009763_increased_sensitivity_to | 0.72005259 |
| 45 | MP0003011_delayed_dark_adaptation | 0.70938546 |
| 46 | MP0003638_abnormal_response/metabolism_ | 0.67575610 |
| 47 | MP0002971_abnormal_brown_adipose | 0.67392991 |
| 48 | MP0000566_synostosis | 0.65932323 |
| 49 | MP0002168_other_aberrant_phenotype | 0.65617340 |
| 50 | MP0005464_abnormal_platelet_physiology | 0.64329681 |
| 51 | MP0005670_abnormal_white_adipose | 0.64201867 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.56992548 |
| 53 | MP0003690_abnormal_glial_cell | 0.56831029 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 0.53369008 |
| 55 | MP0009764_decreased_sensitivity_to | 0.52531154 |
| 56 | MP0002282_abnormal_trachea_morphology | 0.52420780 |
| 57 | MP0005535_abnormal_body_temperature | 0.47664436 |
| 58 | MP0008874_decreased_physiological_sensi | 0.45523605 |
| 59 | MP0005266_abnormal_metabolism | 0.45352139 |
| 60 | MP0008872_abnormal_physiological_respon | 0.44689980 |
| 61 | MP0005334_abnormal_fat_pad | 0.43912381 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 0.43716342 |
| 63 | MP0000249_abnormal_blood_vessel | 0.42565213 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 0.42075285 |
| 65 | MP0005023_abnormal_wound_healing | 0.42063050 |
| 66 | MP0005164_abnormal_response_to | 0.38611855 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.38608497 |
| 68 | MP0010386_abnormal_urinary_bladder | 0.37978762 |
| 69 | MP0005448_abnormal_energy_balance | 0.37628380 |
| 70 | MP0004883_abnormal_blood_vessel | 0.36717924 |
| 71 | MP0003959_abnormal_lean_body | 0.36178034 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.35270061 |
| 73 | MP0003718_maternal_effect | 0.33787821 |
| 74 | MP0003329_amyloid_beta_deposits | 0.33644893 |
| 75 | MP0003953_abnormal_hormone_level | 0.33330247 |
| 76 | MP0005083_abnormal_biliary_tract | 0.32895060 |
| 77 | MP0002928_abnormal_bile_duct | 0.32184439 |
| 78 | MP0004272_abnormal_basement_membrane | 0.31115792 |
| 79 | MP0003075_altered_response_to | 0.30444846 |
| 80 | MP0009785_altered_susceptibility_to | 0.29050679 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.28921077 |
| 82 | MP0001756_abnormal_urination | 0.27818427 |
| 83 | MP0003122_maternal_imprinting | 0.27016468 |
| 84 | MP0009115_abnormal_fat_cell | 0.26907523 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.25202275 |
| 86 | MP0005166_decreased_susceptibility_to | 0.24864740 |
| 87 | MP0008873_increased_physiological_sensi | 0.24717123 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.24716805 |
| 89 | MP0005197_abnormal_uvea_morphology | 0.23385603 |
| 90 | MP0002090_abnormal_vision | 0.23245296 |
| 91 | MP0005647_abnormal_sex_gland | 0.22473884 |
| 92 | MP0004130_abnormal_muscle_cell | 0.21583053 |
| 93 | MP0002970_abnormal_white_adipose | 0.21151449 |
| 94 | MP0000920_abnormal_myelination | 0.20926144 |
| 95 | MP0003632_abnormal_nervous_system | 0.20674412 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.20631949 |
| 97 | MP0001845_abnormal_inflammatory_respons | 0.19106016 |
| 98 | MP0001851_eye_inflammation | 0.16547817 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.16040003 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.14709077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.18540394 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.10728707 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 8.08103926 |
| 4 | Complement deficiency (HP:0004431) | 7.95476291 |
| 5 | Joint hemorrhage (HP:0005261) | 6.44920511 |
| 6 | Abnormality of complement system (HP:0005339) | 6.39853088 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.81035180 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 5.55234662 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.32602830 |
| 10 | Xanthomatosis (HP:0000991) | 5.13084054 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 5.00235829 |
| 12 | Glomerulonephritis (HP:0000099) | 4.91170167 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.83439548 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.70248315 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.70149176 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93587749 |
| 17 | Fat malabsorption (HP:0002630) | 3.90365114 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.75286943 |
| 19 | Spontaneous abortion (HP:0005268) | 3.71928429 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66008406 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.62676606 |
| 22 | Nephritis (HP:0000123) | 3.46767014 |
| 23 | Steatorrhea (HP:0002570) | 3.41944495 |
| 24 | Hyperglycinemia (HP:0002154) | 3.35771844 |
| 25 | Hyperammonemia (HP:0001987) | 3.22510979 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.16290005 |
| 27 | Vascular calcification (HP:0004934) | 3.16186721 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.13655968 |
| 29 | Hemorrhage of the eye (HP:0011885) | 3.09405666 |
| 30 | Rickets (HP:0002748) | 3.06839499 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 3.03789197 |
| 32 | Hypoalphalipoproteinemia (HP:0003233) | 3.01498153 |
| 33 | Menorrhagia (HP:0000132) | 2.93843737 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 2.92122526 |
| 35 | Gingival bleeding (HP:0000225) | 2.91892425 |
| 36 | Delayed CNS myelination (HP:0002188) | 2.90322760 |
| 37 | Osteomalacia (HP:0002749) | 2.87031851 |
| 38 | Mitral stenosis (HP:0001718) | 2.86324718 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.83280627 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 2.83280627 |
| 41 | Epidermoid cyst (HP:0200040) | 2.82194900 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.79435270 |
| 43 | Purpura (HP:0000979) | 2.74666343 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61295092 |
| 45 | Hyperglycinuria (HP:0003108) | 2.59248190 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.51576892 |
| 47 | Pulmonary embolism (HP:0002204) | 2.46356364 |
| 48 | Abnormal gallbladder physiology (HP:0012438) | 2.42359519 |
| 49 | Cholecystitis (HP:0001082) | 2.42359519 |
| 50 | Thrombophlebitis (HP:0004418) | 2.40005436 |
| 51 | Arthropathy (HP:0003040) | 2.38619086 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34494460 |
| 53 | Hyperbilirubinemia (HP:0002904) | 2.29941086 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.25701853 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.21357525 |
| 56 | Fair hair (HP:0002286) | 2.20686569 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.20354545 |
| 58 | Abnormality of urine glucose concentration (HP:0011016) | 2.12451412 |
| 59 | Glycosuria (HP:0003076) | 2.12451412 |
| 60 | Metabolic acidosis (HP:0001942) | 2.08584130 |
| 61 | Abnormality of vitamin metabolism (HP:0100508) | 2.05584506 |
| 62 | Myocardial infarction (HP:0001658) | 2.05164342 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03798639 |
| 64 | Hypophosphatemic rickets (HP:0004912) | 2.00120740 |
| 65 | Deep venous thrombosis (HP:0002625) | 11.3469303 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.0961619 |
| 67 | Bifid scrotum (HP:0000048) | 1.98747214 |
| 68 | Irritability (HP:0000737) | 1.93072960 |
| 69 | Cholelithiasis (HP:0001081) | 1.90938854 |
| 70 | Poikilocytosis (HP:0004447) | 1.89734635 |
| 71 | Elevated alkaline phosphatase (HP:0003155) | 1.87822122 |
| 72 | Hydroxyprolinuria (HP:0003080) | 1.87090070 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 1.87090070 |
| 74 | Acanthocytosis (HP:0001927) | 1.84570377 |
| 75 | Ketosis (HP:0001946) | 1.83558660 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 1.82807849 |
| 77 | Gangrene (HP:0100758) | 1.82369406 |
| 78 | Abnormal urine phosphate concentration (HP:0012599) | 1.78710026 |
| 79 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77542099 |
| 80 | Neonatal hypoglycemia (HP:0001998) | 1.76541799 |
| 81 | Hypochromic microcytic anemia (HP:0004840) | 1.76070967 |
| 82 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72701879 |
| 83 | Facial shape deformation (HP:0011334) | 1.70671262 |
| 84 | Potter facies (HP:0002009) | 1.70671262 |
| 85 | Enlarged kidneys (HP:0000105) | 1.69845948 |
| 86 | Skin nodule (HP:0200036) | 1.68268484 |
| 87 | Retinal atrophy (HP:0001105) | 1.67641657 |
| 88 | Pancreatitis (HP:0001733) | 1.66491762 |
| 89 | Abnormality of purine metabolism (HP:0004352) | 1.65570304 |
| 90 | Abnormal tarsal ossification (HP:0008369) | 1.63265269 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 1.62586930 |
| 92 | Increased mean platelet volume (HP:0011877) | 1.62131801 |
| 93 | Increased serum ferritin (HP:0003281) | 1.61607317 |
| 94 | Epistaxis (HP:0000421) | 1.59105161 |
| 95 | Abnormal biliary tract physiology (HP:0012439) | 1.58415775 |
| 96 | Bile duct proliferation (HP:0001408) | 1.58415775 |
| 97 | Hypochromic anemia (HP:0001931) | 1.56859513 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.56718042 |
| 99 | Joint swelling (HP:0001386) | 1.56025329 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.54819161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 5.63679760 |
| 2 | ERN1 | 4.67198055 |
| 3 | PIK3CG | 3.46885094 |
| 4 | RIPK1 | 3.43046150 |
| 5 | FGFR3 | 2.95404610 |
| 6 | LATS1 | 2.48530734 |
| 7 | PIK3CA | 2.44348526 |
| 8 | MAP3K3 | 2.40485141 |
| 9 | TRIB3 | 2.38030129 |
| 10 | TYK2 | 1.94005564 |
| 11 | BCKDK | 1.90208804 |
| 12 | MAP3K12 | 1.89887025 |
| 13 | PRKACG | 1.85107123 |
| 14 | SIK1 | 1.80640326 |
| 15 | PRKAA2 | 1.75620135 |
| 16 | NEK9 | 1.73178412 |
| 17 | ICK | 1.68060200 |
| 18 | MAP3K2 | 1.58870950 |
| 19 | STK38L | 1.57916790 |
| 20 | MAPK11 | 1.56323263 |
| 21 | MST1R | 1.53582968 |
| 22 | PDPK1 | 1.52461507 |
| 23 | IRAK3 | 1.47785096 |
| 24 | TBK1 | 1.41051887 |
| 25 | PRKCG | 1.37477606 |
| 26 | NTRK3 | 1.35619786 |
| 27 | FGFR2 | 1.32869183 |
| 28 | PRPF4B | 1.23318435 |
| 29 | MAP2K4 | 1.21279330 |
| 30 | LATS2 | 1.20568335 |
| 31 | IGF1R | 1.10329817 |
| 32 | TGFBR2 | 1.08832181 |
| 33 | ABL2 | 1.07804994 |
| 34 | ERBB2 | 1.01583486 |
| 35 | CDK12 | 1.00932997 |
| 36 | EPHA2 | 1.00234215 |
| 37 | MYLK | 0.98096401 |
| 38 | NLK | 0.97628418 |
| 39 | EPHA3 | 0.95940917 |
| 40 | EIF2AK1 | 0.95165407 |
| 41 | PRKCZ | 0.94007946 |
| 42 | PKN2 | 0.93413869 |
| 43 | PDK1 | 0.92968894 |
| 44 | RET | 0.91935447 |
| 45 | STK38 | 0.90968658 |
| 46 | EPHA4 | 0.86562722 |
| 47 | WNK4 | 0.86471110 |
| 48 | MAP2K3 | 0.85655027 |
| 49 | DYRK1B | 0.84139234 |
| 50 | MAP3K1 | 0.82022794 |
| 51 | JAK1 | 0.81070355 |
| 52 | KSR2 | 0.80997231 |
| 53 | PDGFRA | 0.80845155 |
| 54 | FGFR1 | 0.80441001 |
| 55 | CSNK1D | 0.79249645 |
| 56 | MAP3K11 | 0.77832950 |
| 57 | MAPKAPK3 | 0.77526129 |
| 58 | LMTK2 | 0.74779675 |
| 59 | PRKAA1 | 0.73974410 |
| 60 | PDK2 | 0.72631923 |
| 61 | MAP3K5 | 0.70917292 |
| 62 | SGK223 | 0.70340139 |
| 63 | SGK494 | 0.70340139 |
| 64 | PRKG1 | 0.69464176 |
| 65 | PRKACA | 0.69144887 |
| 66 | TAOK2 | 0.68743899 |
| 67 | SGK1 | 0.68434054 |
| 68 | JAK2 | 0.62421258 |
| 69 | PINK1 | 0.61220745 |
| 70 | CSF1R | 0.61209179 |
| 71 | ACVR1B | 0.59483271 |
| 72 | SCYL2 | 0.56895279 |
| 73 | AKT3 | 0.55797512 |
| 74 | SGK3 | 0.53432783 |
| 75 | MAP2K2 | 0.52742125 |
| 76 | CDK6 | 0.52600529 |
| 77 | RPS6KA3 | 0.51271405 |
| 78 | TAOK3 | 0.50256966 |
| 79 | MET | 0.50074768 |
| 80 | FER | 0.49180420 |
| 81 | PRKCB | 0.48860167 |
| 82 | INSRR | 0.48280234 |
| 83 | PTK6 | 0.48208444 |
| 84 | ARAF | 0.47764151 |
| 85 | SGK2 | 0.47255555 |
| 86 | PRKCA | 0.46031609 |
| 87 | CSNK1E | 0.45709625 |
| 88 | SRC | 0.43726170 |
| 89 | ERBB4 | 0.43131285 |
| 90 | CAMK1D | 0.42667625 |
| 91 | BCR | 0.41650207 |
| 92 | DAPK2 | 0.38480702 |
| 93 | GSK3A | 0.38079876 |
| 94 | ZAP70 | 0.36295997 |
| 95 | CAMKK1 | 0.36120220 |
| 96 | CSNK2A1 | 0.35875283 |
| 97 | CDK4 | 0.35697484 |
| 98 | STK16 | 0.35508433 |
| 99 | MAP3K7 | 0.35085242 |
| 100 | RPS6KB1 | 0.35030188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.09338293 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.05572049 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03254175 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.83365472 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.55897018 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.31303066 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 3.28348811 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.88043425 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.84844976 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.84251976 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.77869195 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.70745178 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.58029700 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48637617 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.47554554 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34131020 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.23212703 |
| 18 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.06207632 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02956715 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.86880003 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79809939 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.78334357 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78324823 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62292220 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60657957 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.54339737 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53189831 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.43739495 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.41716637 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41081208 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34795274 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26436034 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24755603 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24402448 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19785358 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12270693 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12107534 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10528887 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10523888 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09606157 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06909685 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04851555 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.97641178 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97365998 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93124370 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.89989591 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89295244 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84980646 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84038830 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81093135 |
| 51 | Prion diseases_Homo sapiens_hsa05020 | 0.80486685 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78120720 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.69750068 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69629227 |
| 55 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69145047 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68784658 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60609456 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.56122988 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47863652 |
| 60 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44364150 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40698642 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38309003 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36411040 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36213136 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29430458 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29249225 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.26768145 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22480480 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20347937 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18869443 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.18130424 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.18006087 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16629508 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14560323 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.10361694 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10301432 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07809713 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03990657 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.02759772 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.02513492 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2160707 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2037623 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1731463 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1617999 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1519885 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1431381 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | -0.1312462 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1238789 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1163818 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1081681 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0997112 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0823318 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0775788 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0759969 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0645355 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0617126 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0615868 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0596614 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0423292 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | -0.0236950 |

